Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data March ...
The American College of Lifestyle Medicine (ACLM) announces the launch of Project Remission: A Lifestyle Medicine Approach to ...
The team led by Prof. Mary E. Jung and Prof. Jonathan P. Little from University of British Columbia–Okanagan Campus performed ...
Phase 2 TBCRC049 trial results show tucatinib triplet therapy improves survival in HER2+ breast cancer patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results